Cross-sectional analysis of late HARRT initiation in Latin America and the Caribbean: Late testers and late presenters

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Crabtree Ramírez, Brenda ^a   Caro Vega, Yanink ^a   Shepherd, Bryan E ^b   Wehbe, Firas ^b   Cesar, Carina ^c   Cortés, Claudia ^d   Padgett, Denis ^e   Koenig, Serena ^f,g   Gotuzzo, Eduardo ^h   Cahn, Pedro ^c   McGowan, Catherine ^b   Masys, Daniel ^b   Sierra Madero, Juan ^a   The CCASAnet Team, ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b VANDERBILT UNIVERSITY   (United States)

^c FUNDACIÓN HUÉSPED   (Argentina)

^d UNIVERSITY OF CHILE   (Chile)

^e Inst Hondureno de Seguridad Social   (Honduras)

^f WEILL CORNELL MEDICAL COLLEGE   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

^h INSTITUTO DE MEDICINA TROPICAL ALEXANDER VON HUMBOLDT   (Peru)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARGENTINA; ARTICLE; CD4 LYMPHOCYTE COUNT; CHILE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EDUCATION; FEMALE; HAITI; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HONDURAS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEXICO; PERU; PREVALENCE; RISK FACTOR; SEX DIFFERENCE; THERAPY DELAY; CENTRAL AMERICA; METHODOLOGY; MULTIVARIATE ANALYSIS; SOUTH AND CENTRAL AMERICA; TIME;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CARIBBEAN REGION; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LATIN AMERICA; MALE; MULTIVARIATE ANALYSIS; RISK FACTORS; TIME FACTORS;

EID: 79957566353     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020272     Document Type: Article

References (45)

1. Pallela F, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 338 (13): 853-60.
2. Castilla J, Sobrino P, De La Fuente L, Noguer I, Guerra L, et al. (2002) Late diagnosis of HIV infection in the era of highly active antiretroviral therapy: consequences for AIDS incidence. AIDS 16 (14): 1945-51.
3. Chadborn TR, Bastera K, Delpecha VC, Sabin CA, Sinka K, et al. (2005) No time to wait: how many HIV-infected homosexual men are diagnosed late and consequently die? (England and Wales, 1993-2002) AIDS 19: 513-520.
4. Chadborn TR, Delpecha VC, Sabin CA, Sinka C, Evans BG, (2006) The late diagnosis and consequent short-term mortality of HIV-infected heterosexuals (England and Wales, 2000-2004). AIDS 20: 2371-2379.
5. Egger M, May M, Chêne G, Phillips AN, Ledergerber B, et al. (2002) Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. The ART Cohort Collaboration. The Lancet 360 (9327): 119-129.
6. Hocking JS, Rodger AJ, Rhodes DG, Crofts N, (2000) Late presentation of HIV infection associated with prolonged survival following AIDS diagnosis-characteristics of individuals. Int J STD AIDS 11 (8): 503-8.
7. Krentz HB, Auld MC, Gill MJ, (2004) The high cost of medical care for patients who present late (CD4, 200 cells/mL) with HIV infection. HIV Med 5: 93-98.
8. Sabin CA, Smith CJ, Gumley H, Murphy G, Lampe FC, et al. (2004) Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy. AIDS 18 (16): 2145-51.
9. Cesar C, Shepherd BE, Krolewiecki AJ, Fink VI, Schechter M, et al. (2010) Caribbean, Central and South America Network for HIV Research (CCASAnet) Collaboration of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) Program. Rates and reasons for early change of first HAART in HIV-1-infected patients in 7 sites throughout the Caribbean and Latin America. PLoS One 5 (6): e10490.
10. Tuboi SH, Schechter M, McGowan CC, Cesar C, Krolewiecki A, et al. (2009) Mortality During the First Year of Potent Antiretroviral Therapy in HIV-1-Infected Patients in 7 Sites Throughout Latin America and the Caribbean. J Acquir Immune Defic Synd 51: 615-623.
11. Mills E, Bakanda C, Birungi J, Mwesigwa R, Chan K, et al. (2011) Mortality by baseline CD4 cell count among HIV patients initiating antiretroviral therapy: evidence from a large cohort in Uganda. AIDS pp. 851-55.
12. Sterne JA, May M, Costagliola D, de Wolf F, et al. When To Start Consortium (2009) Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet 373 (9672): 1352-63.
13. Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, et al. (2009) NA-ACCORD Investigators. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med 360 (18): 1815-26.
14. Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, et al. (2003) EuroSIDA study group. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet 362 (9377): 22-9.
15. Severe P, Juste MA, Ambroise A, Eliacin L, Marchand C, et al. (2010) Early versus standard antiretroviral therapy for HIV-infected adults in Haiti. N Engl J Med 363 (3): 257-65.
16. Castilla J, Del Romero J, Hernando V, Marincovich B, García S, et al. (2005) Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. J Acquir Immune Defic Syndr 40 (1): 96-101.
17. Lima VD, Johnston K, Hogg RS, Levy AR, Harrigan PR, et al. (2008) Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic. J Infect Dis 198 (1): 59-67.
18. Girardi E, Aloisi MS, Arici C, Pezzotti P, Serraino D, et al. for the ICoNA Behavioural Epidemiology Study Group (2004) Delayed presentation and late testing for HIV: demographic and behavioral risk factors in a multicenter study in Italy. J Acquir Immune Defic Syndr 36 (4): 951-9.
19. The UK Collaborative HIV Cohort (UK CHIC) Steering Committee (2010) Late diagnosis in the HAART era: proposed common definitions and associations with mortality. AIDS 24 (5): 723-7.
20. Fisher M, (2008) Late diagnosis of HIV infection: major consequences and missed opportunities. Curr Opin Infect Dis 21 (1): 1-3.
21. Centers for Disease Control and Prevention (CDC) Missed opportunities for earlier diagnosis of HIV infection-South Carolina, 1997-2005. MMWR Morb Mortal Wkly Rep 2006 55 (47): 1269-72.
22. Nash D, Katyal M, Brinkhof MW, Keiser O, May M, et al. (2008) ART-LINC Collaboration of IeDEA. Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies. AIDS 22 (17): 2291-302.
23. Bonjour MA, Montagne M, Zambrano M, Molina G, Lippuner C, et al. (2008) Determinants of late disease-stage presentation at diagnosis of HIV infection in Venezuela: a case-case comparison. AIDS Res Ther 5: 6 DOI:10.1186/1742-6405-5-6.
24. McGowan CC, Cahn P, Gotuzzo E, Padgett D, Paper JW, et al. (2007) Cohort Profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme. Int J Epidemiol 36 (5): 969-76.
25. Friedman JH, (1984) SMART User's Guide. Laboratory for Computational Statistics, Stanford University Technical Report No. 1.
26. Harrell FE, (2001) Regression Modeling Strategies with Applications to Linear Models, Logistic Regression, and Survival Analysis New York, NY Springer.
27. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7 (3): 177-88.
28. Smith-Warner SA, Spiegelman D, Ritz J, Albanes D, Beeson W, et al. (2006) Methods for pooling results of epidemiologic studies: the Pooling Project of Prospective Studies of Diet and Cancer. Am J Epidemiol 163 (11): 1053-64 Available: http://aje.oxfordjournals.org/content/163/11/1053.full.pdfhtml. Accessed 22 March 2011.
29. Shafer J, (1997) Analysis of Incomplete Multivariate Data London, United Kingdom Chapman & Hall.
30. WHO (2010) Antiretroviral therapy for HIV infection in adults and adolescents: Recommendation for a public health approach Geneva, Switzerland.
31. EACS (2009) Clinical Management and Treatment of HIV infected Adults in Europe.
32. OARAC (2009) Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Developed by the DHHS Panel - A Working Group of the Office of AIDS Research Advisory Council.
33. Gilks CF, Crowley S, Epkini R, Gove S, Perriens J, et al. (2006) The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet 368 (9534): 505-10.
34. Walensky RP, Wolf LL, Wood R, Fofana MO, Freedberg KA, et al. (2009) When to start antiretroviral therapy in resource-limited settings. Ann Intern Med 151: 157-66.
35. Schwarcz S, Hsu L, Dilley JW, Loeb L, Nelson K, et al. (2006) Late diagnosis of HIV infection: trends, prevalence, and characteristics of persons whose HIV diagnosis occurred within 12 months of developing AIDS. J Acquir Immune Defic Syndr 43 (4): 491-4.
36. Assefa Y, Van Damme W, Mariam DH, Kloos H, (2010) Toward universal access to HIV counseling and testing and antiretroviral treatment in Ethiopia: looking beyond HIV testing and ART initiation. AIDS Patient Care STDS 24 (8): 521-5.
37. Losina E, Basset IV, Giddy J, Chetty S, Regan S, et al. (2010) The "ART" of linkage: pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South Africa. PLoS One 5 (3): e9538.
38. Zala C, Rustad CA, Chan K, Khan NI, Beltran M, et al. (2008) Determinants of treatment access in a population-based cohort of HIV-positive men and women living in Argentina. Medscape J Med 10 (4): 78.
39. Althoff KN, Gange SJ, Klein MB, Brooks JT, Hogg RS, et al. (2010) Late presentation for human immunodeficiency virus care in the United States and Canada. Clin Infect Dis 50 (11): 1512-20.
40. WHO (2004) Scaling up antiretroviral therapy in resource-limited settings Geneva, Switzerland.
41. WHO (2006) Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach: 2006 revision Geneva, Switzerland.
42. SADI (2007) Recomendaciones para el seguimiento y tratamiento de la infección por HIV. Available: http://www.sadi.org.ar/images/HIV2007.pdf. Accessed 22 March 2011.
43. Ministerio de Salud (2007) Recomendaciones para el tratamiento antirretroviral 2007. Available: http://www.msal.gov.ar/sida/pdf/info-equipos-salud/recomendaciones-tratamiento-antirretroviral.pdf. Accessed 22 March 2011.
44. CENSIDA (2008) Guía de manejo antirretroviral de las personas con VIH. Cuarta edición. México. Available: Centro Nacional para la Prevención y el Control del VIH/SIDA. http://www.censida.salud.gob.mx/interior/atencion.html. Accessed 8 November 2010.
45. Ministerio de Salud (2005) Guía Clínica Síndrome de la Inmunodeficiencia Adquirida VIH/SIDA. 1st Ed. Santiago.